Five-year clinical outcomes of a 2.25 mm sirolimus-eluting stent in Japanese patients with very small coronary artery disease: final results of the CENTURY JSV study
Authors:
Open Access
- 2 September 2022
- journal article
- research article
- Published by Springer Nature in Cardiovascular Intervention and Therapeutics
- Vol. 38 (2) , 194-201
Abstract
The aim of this study is to evaluate the long-term safety and efficacy of the 2.25 mm bioresorbable-polymer sirolimus-eluting Ultimaster stent in a Japanese patient population. Treatment of coronary artery disease in very small vessels is associated with an increased risk for cardiac events. The CENTURY JSV study is a prospective, multicenter, single-arm study. Seventy patients with stable and unstable coronary artery disease with a coronary lesion eligible for implantation with a 2.25 mm stent were enrolled in this study. Patients underwent clinical follow-up through 5-year after the PCI procedure. The mean age was 70.4 ± 9.2 years. The prevalence of diabetes mellitus was 37.1%, all not insulin dependent. The incidence of major adverse cardiac events, defined as cardiac death, target vessel myocardial infarction (MI), and clinically driven target lesion revascularization (CD-TLR) at 5 years was 5.7%. A non-Q wave MI was noted in 1.4% and 4.3% underwent a CD-TLR. There was no stent thrombosis during the entire follow-up period. No cardiac events were reported between 2 and 5 years. This is the first study to demonstrate safety and effectiveness for 5 years after treatment of very small coronary disease with 2.25 mm-diameter DES.Clinical trial registration: UMIN000012928Keywords
Funding Information
- Terumo
This publication has 35 references indexed in Scilit:
- Association of prediabetes with diffuse coronary narrowing and small-vessel diseaseJournal of Cardiology, 2014
- Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiographyHeart, 2013
- A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary VesselsJACC, 2012
- Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stentingAmerican Heart Journal, 2011
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO StudyHeart, 2010
- Percutaneous coronary intervention for small vessel coronary artery diseaseCardiovascular Revascularization Medicine, 2010
- Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable PolymerJACC: Cardiovascular Interventions, 2009
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Effect of Coronary Artery Diameter in Patients Undergoing Coronary Bypass SurgeryCirculation, 1996